86.5%
glucagon-like peptide-1 receptor agonistssodium–glucose cotransporter-2 inhibitorsMetformin156Thiazolidinedione43Sulfonylurea227Insulin71A1c TIRDiabetes medications
…dications, such as sodium–glucose cotransporter-2 inhibitors or glucagon-like peptide-1 receptor agonists, which have been shown to reduce cardiovascular and renal outco…